ID   BIHi001-A-2
AC   CVCL_C0NJ
SY   AAVS1-Puro-CAG-eGFP targeted hiPSC
DR   hPSCreg; BIHi001-A-2
DR   Wikidata; Q112929326
RX   PubMed=32384610;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a Puro-CAG-eGFP construct was introduced in the AAVS1 safe harbor locus (PubMed=32384610).
CC   Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP).
CC   Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IT54 ! BIHi001-A
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
RX   PubMed=32384610; DOI=10.3390/genes11050511;
RA   Surun D., Schneider A., Mircetic J., Neumann K., Lansing F.,
RA   Paszkowski-Rogacz M., Hanchen V., Lee-Kirsch M.A., Buchholz F.;
RT   "Efficient generation and correction of mutations in human iPS cells
RT   utilizing mRNAs of CRISPR base editors and prime editors.";
RL   Genes (Basel) 11:511.1-511.19(2020).
//